Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 7,400 shares, a growth of 39.6% from the February 13th total of 5,300 shares. Based on an average daily volume of 15,500 shares, the short-interest ratio is presently 0.5 days. Currently, 0.0% of the company’s stock are sold short.
Bavarian Nordic A/S Trading Up 2.8 %
Shares of OTCMKTS BVNRY opened at $8.10 on Monday. The firm’s 50-day moving average price is $8.42 and its 200-day moving average price is $9.65. Bavarian Nordic A/S has a 1-year low of $6.86 and a 1-year high of $14.60. The firm has a market capitalization of $1.92 billion, a P/E ratio of 11.74 and a beta of 1.83.
Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) last posted its earnings results on Wednesday, March 5th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.40 by $0.07. The company had revenue of $299.48 million during the quarter, compared to the consensus estimate of $264.06 million. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. Equities research analysts forecast that Bavarian Nordic A/S will post 0.67 EPS for the current year.
About Bavarian Nordic A/S
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Stories
- Five stocks we like better than Bavarian Nordic A/S
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- How to Build the Ultimate Everything ETF Portfolio
- What is the Dow Jones Industrial Average (DJIA)?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Differences Between Momentum Investing and Long Term Investing
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.